prestige8k110807.htm




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):   November 8, 2007


PRESTIGE BRANDS HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
 
Delaware 
001-32433 
20-1297589
(State or other jurisdiction  
(Commission File Number)
(IRS Employer
of incorporation)
 
Identification No.)
              
90 North Broadway, Irvington, New York 10533
(Address of principal executive offices, including Zip Code)

 (914) 524-6810
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 

Item 2.02 Results of Operations and Financial Condition.

On November 8, 2007, Prestige Brands Holdings, Inc. (the “Registrant”) announced financial results for the fiscal quarter and six months ended September 30, 2007.  A copy of the press release announcing the Registrant’s earnings results for the fiscal quarter and six months ended September 30, 2007 is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be ‘‘filed’’ for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, unless the Registrant specifically states that the information is to be considered “filed” under the Securities Exchange Act of 1934 or incorporates it by reference into a filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

Item 7.01.  Regulation FD Disclosure.

The information set forth in Item 2.02 above is incorporated by reference as if fully set forth herein.

Item 9.01 Financial Statements and Exhibits.

(d)  
Exhibits.
 
Exhibit
 
Description
   
   
99.1 Press Release dated November 8, 2007 announcing the Registrant’s financial results for the fiscal quarter and six months ended September 30,
  2007 (furnished only).
   
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
Dated:  November 8, 2007   PRESTIGE BRANDS HOLDINGS, INC.  
       
       
  By: /s/ Peter J. Anderson  
  Name: Peter J. Anderson  
  Title: Chief Financial Officer

 
       
       
                                                                           

                                                  
      
                                                            

EXHIBIT INDEX
 
 
Exhibit
 
Description
   
   
99.1 Press Release dated November 8, 2007 announcing the Registrant’s financial results for the fiscal quarter and six months ended September 30,
  2007 (furnished only).
   
   
 
 

 
 

 

 
pbhexhibit991.htm
Exhibit 99.1
 
Prestige Brands Holdings, Inc. Reports Second Quarter & Six Months Fiscal 2008 Results

Irvington, NY, November 8, 2007—Prestige Brands Holdings, Inc. (NYSE-PBH) today announced results for the second quarter and first half of fiscal year 2008, which ended on September 30, 2007.

Net revenues for the second fiscal quarter ended September 30, 2007 were $87.3 million, 3% higher than net revenues of $84.6 million in the prior year comparable period.  Net revenues for the quarter would have been 4% higher, and organic sales for the quarter would have been 2% higher than the prior year quarter were it not for the industry-wide voluntary withdrawal of infant cough/cold products in which the Company participated that affected two Little Remedies® products.  During the quarter, the Company increased its allowance for estimated returns by $1.1 million and its allowance for obsolescence by $0.8 million to reflect the two withdrawn items.

Operating income of $20.6 million was 15% lower than the prior year quarter operating income of $24.1 million.  The reduction in operating income is primarily due to the impact of the Little Remedies withdrawal, as well as increased legal expenditures related to arbitration with OraSure Technologies, Inc., a supplier of Compound W Freeze Off®, and four separate legal actions initiated by the Company involving infringements of its intellectual property relative to its The Doctor’s® Night Guard™ products.

Net income for the second fiscal quarter of $6.8 million, or $0.14 per share, was below last fiscal year’s second quarter net income of $8.8 million, or $0.18 per share.  Excluding the effects of the voluntary Little Remedies withdrawal, net income would have been $8.1 million, or $0.16 per share.

First Six Months of Fiscal 2008
Net revenues for the first six months of fiscal 2008 were $165.9 million, an increase of 3% over the prior year comparable period results of $160.5 million.  Operating income of $43.7 million was 8% below the comparable period’s results of $47.5 million.  Net income of $15.1 million, or $0.30 per share, was 11% below the comparable period’s net income of $17.0 million, or $0.34 per share.


Q2 and Six Month Results by Segment

Over-the-Counter (OTC) Healthcare Products
Net revenues of OTC healthcare products increased 8% to $50.0 million over the comparable period’s results of $46.3 million. Excluding the impact of the acquisition of Wartner® wart remover products in the second quarter of fiscal 2007 and the effects of the increased allowance for returns for the two Little Remedies® products, OTC organic sales increased by 5%.  Increases in the segment were led by the successful introduction of new Murine™ Earigate™ and Clear Eyes® eye care products.

For the six month period ended September 30, 2007, OTC net revenues were $92.4 million compared to $85.9 million in the prior year comparable period, an increase of 8%.

Household Products
Net revenues for the household products segment were $31.4 million, even with the prior year comparable quarter.  An increase in the Chore Boy® line of household scrubbers offset a decline in sales of Spic and Span® household cleaners.  Revenues for Comet®, the segment’s largest brand, were even with the prior year comparable period.  The sales increase generated from the successful introduction of Comet® SprayGel Mildew Stain Remover was offset by inventory reductions at one of our key mass merchandisers.

For the six month period ended September 30, 2007, net revenues for the household products segment were $61.3 million, even with the prior year comparable period.

Personal Care Products
Net revenues for the personal care products segment were $5.9 million, 16% lower than the prior year comparable period results of $7.0 million.  Cutex® nail polish remover and Denorex® shampoo experienced sales decreases versus the prior year period in line with expectations.  Revenues of Prell® shampoo were up slightly for the quarter.

For the first six months of fiscal 2008, net revenues were $12.2 million compared to $13.3 million in the prior year comparable period.


Free Cash Flow and Debt Repayment
Free cash flow is a “non-GAAP” financial measure as that term is defined by the Securities and Exchange Commission in Regulation G.  Free cash flow is presented in this news release because management believes that it is a commonly used measure of liquidity, and indicative of cash available for debt repayment and acquisitions.  The Company defines “free cash flow” as operating cash flow less capital expenditures.

The Company’s free cash flow for the quarter ended September 30, 2007 was $13.0 million, composed of operating cash flow of $13.1 million less capital expenditures of $0.1 million.  This compares to free cash flow of $21.3 million generated in the prior year quarter.  The decline in free cash flow was driven by the year on year reduction in net income combined with an increase in working capital versus the prior year comparable period.

Our continued strong absolute cash flow resulted in a debt pay down of $10.4 million on our term loan during the second fiscal quarter.  Total debt has been reduced to $437.1 million at September 30, 2007.

Commentary
“Our second quarter saw continued progress on the path to sustainable organic growth,” said Mark Pettie, Chairman and CEO.  “Were it not for the industry-wide voluntary withdrawal affecting two of our Little Remedies® products, our organic sales would have been 2% above the year ago comparable period, aided by new product innovation in both our OTC and household businesses.  In addition, efforts toward cost of goods savings are beginning to take effect and have already helped to shelter us from raw material increases,” he said.

Conference Call
The Company will host a conference call to review its second quarter and six month results on Thursday, November 8, 2007 at 8:30 am (ET). The toll free number is 1-800-299-7635 within North America and 1-617-786-2901 outside North America. The conference pass code is “prestige”. Telephonic replays will be available for two weeks following the completion of the call and can be accessed at 1-888-286-8010 within North America, and at 1-617-801-6888 outside of North America. The pass code is 72463596.

About Prestige Brands Holdings, Inc.


Prestige Brands markets and distributes brand name over-the-counter healthcare, personal care and household products sold throughout the United States, Canada and certain international markets. Key brands include Compound W(R) wart treatment, Chloraseptic(R) sore throat relief products, New Skin(R) liquid bandage, Clear Eyes(R) and Murine(R) eye care products, Little Remedies(R) pediatric over-the-counter healthcare products, The Doctor's(R)NightGuard(TM), Cutex(R) nail polish remover, Comet(R) and Spic and Span(R) household cleaners, and other well-recognized brands.
 
Forward Looking Statements
 
Note: This news release contains "forward-looking statements" within the meaning of the federal securities laws and is intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe, "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the outlook for Prestige Brands Holdings' market and the demand for its products, earnings per share, future cash flows from operations, future revenues and margin requirement and expansion, the success of new product introductions, growth in costs and expenses, and the impact of acquisitions, divestitures, restructurings and other unusual items, including Prestige Brands Holdings' ability to integrate and obtain the anticipated results and synergies from its acquisitions. These projections and statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those projected as a result of certain factors. A discussion of factors that could cause results to vary is included in the Company's Annual Report on Form 10-K and other periodic and other reports filed with the Securities and Exchange Commission.
 
Contact: Dean Siegal
 
914-524-6819
 

Prestige Brands Holdings, Inc.
Consolidated Statements of Operations
(Unaudited)


   
Three Months
Ended September 30
   
Six Months
Ended September 30
 
(In thousands, except per share data)
 
2007
   
2006
   
2007
   
2006
 
Revenues
                       
Net sales
  $
86,840
    $
84,033
    $
164,881
    $
159,600
 
Other revenues
   
497
     
518
     
1,067
     
874
 
Total revenues
   
87,337
     
84,551
     
165,948
     
160,474
 
                                 
Cost of Sales
                               
Costs of sales
   
42,770
     
41,259
     
80,092
     
77,584
 
Gross profit
   
44,567
     
43,292
     
85,856
     
82,890
 
                                 
Operating Expenses
                               
Advertising and promotion
   
11,017
     
9,455
     
18,803
     
16,857
 
General and administrative
   
10,184
     
7,259
     
17,830
     
13,693
 
Depreciation
   
129
     
219
     
253
     
439
 
Amortization of intangible assets
   
2,627
     
2,193
     
5,254
     
4,386
 
Total operating expenses
   
23,957
     
19,126
     
42,140
     
35,375
 
                                 
Operating income
   
20,610
     
24,166
     
43,716
     
47,515
 
                                 
Other income (expense)
                               
Interest income
   
173
     
403
     
360
     
588
 
Interest expense
    (9,768 )     (10,146 )     (19,642 )     (20,123 )
Total other income (expense)
    (9,595 )     (9,743 )     (19,282 )     (19,535 )
                                 
Income before provision for
income taxes
   
11,015
     
14,423
     
24,434
     
27,980
 
                                 
Provision for income taxes
   
4,186
     
5,639
     
9,285
     
10,940
 
Net income
  $
6,829
    $
8,784
    $
15,149
    $
17,040
 
                                 
                                 
Basic earnings per share
  $
0.14
    $
0.18
    $
0.30
    $
0.35
 
                                 
Diluted earnings per share
  $
0.14
    $
0.18
    $
0.30
    $
0.34
 
                                 
Weighted average shares outstanding:
Basic
   
49,710
     
49,451
     
49,686
     
49,389
 
Diluted
   
50,046
     
49,994
     
50,042
     
49,991
 


Prestige Brands Holdings, Inc.
Consolidated Balance Sheets
(Unaudited)

(In thousands)
Assets
 
September 30, 2007
   
March 31, 2007
 
Current assets
           
Cash and cash equivalents
  $
8,799
    $
13,758
 
Accounts receivable
   
46,512
     
35,167
 
Inventories
   
27,783
     
30,173
 
Deferred income tax assets
   
3,337
     
2,735
 
Prepaid expenses and other current assets
   
3,628
     
1,935
 
Total current assets
   
90,059
     
83,768
 
                 
Property and equipment
   
1,391
     
1,449
 
Goodwill
   
308,915
     
310,947
 
Intangible assets
   
651,903
     
657,157
 
Other long-term assets
   
8,310
     
10,095
 
                 
Total Assets
  $
1,060,578
    $
1,063,416
 
                 
Liabilities and Stockholders’ Equity
               
Current liabilities
               
Accounts payable
  $
21,318
    $
19,303
 
Accrued interest payable
   
7,556
     
7,552
 
Other accrued liabilities
   
12,771
     
10,505
 
Current portion of long-term debt
   
3,550
     
3,550
 
Total current liabilities
   
45,195
     
40,910
 
                 
Long-term debt
   
433,563
     
459,800
 
Other long-term liabilities
   
2,801
     
2,801
 
Deferred income tax liabilities
   
117,609
     
114,571
 
                 
Total Liabilities
   
599,168
     
618,082
 
                 
Stockholders’ Equity
               
Preferred stock - $0.01 par value
               
Authorized – 5,000 shares
               
Issued and outstanding – None
   
--
     
--
 
Common stock - $0.01 par value
               
Authorized – 250,000 shares
               
Issued – 50,060 shares
   
501
     
501
 
Additional paid-in capital
   
380,371
     
379,225
 
Treasury stock, at cost – 57 shares at September 30, 2007
and 55 shares at March 31, 2007
    (44 )     (40 )
Accumulated other comprehensive income
   
98
     
313
 
Retained earnings
   
80,484
     
65,335
 
Total stockholders’ equity
   
461,410
     
445,334
 
                 
Total Liabilities and Stockholders’ Equity
  $
1,060,578
    $
1,063,416
 
 
 

Prestige Brands Holdings, Inc.
Consolidated Statements of Cash Flows
(Unaudited)


   
Six Months Ended September 30
 
(In thousands)
 
2007
   
2006
 
Operating Activities
           
Net income
  $
15,149
    $
17,040
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
5,507
     
4,825
 
Deferred income taxes
   
4,622
     
6,197
 
Amortization of deferred financing costs
   
1,561
     
1,609
 
Stock-based compensation
   
1,146
     
224
 
Changes in operating assets and liabilities
               
Accounts receivable
    (11,345 )    
2,595
 
Inventories
   
2,390
     
5,202
 
Prepaid expenses and other current assets
    (1,692 )     (1,047 )
Accounts payable
   
1,884
     
4,494
 
Income taxes payable
   
--
      (1,731 )
Accrued liabilities
   
2,270
     
3,326
 
Net cash provided by operating activities
   
21,492
     
42,734
 
                 
Investing Activities
               
Purchases of equipment
    (194 )     (313 )
Purchase of business
    (16 )     (31,242 )
Net cash used for investing activities
    (210 )     (31,555 )
                 
Financing Activities
               
Repayment of long-term debt
    (26,237 )     (8,865 )
Purchase of common stock for treasury
    (4 )     (6 )
Net cash used for financing activities
    (26,241 )     (8,871 )
                 
Increase (decrease) in cash
    (4,959 )    
2,308
 
Cash - beginning of period
   
13,758
     
8,200
 
                 
Cash - end of period
  $
8,799
    $
10,508
 
                 
Interest paid
  $
18,078
    $
18,306
 
Income taxes paid
  $
5,664
    $
6,287
 

 

Prestige Brands Holdings, Inc.
Consolidated Segment Operations
(Unaudited)


   
Three Months Ended September 30, 2007
 
   
Over-the-Counter
   
Household
   
Personal
       
   
Healthcare
   
Cleaning
   
Care
   
Consolidated
 
                         
Net sales
  $
50,003
     
30,925
    $
5,912
    $
86,840
 
Other revenues
   
--
     
497
     
--
     
497
 
                                 
Total revenues
   
50,003
     
31,422
     
5,912
     
87,337
 
Cost of sales
   
19,688
     
19,587
     
3,495
     
42,770
 
                                 
Gross profit
   
30,315
     
11,835
     
2,417
     
44,567
 
Advertising and promotion
   
8,154
     
2,575
     
288
     
11,017
 
                                 
Contribution margin
  $
22,161
    $
9,260
    $
2,129
     
33,550
 
Other operating expenses
                           
12,940
 
                                 
Operating income
                           
20,610
 
Other (income) expense
                           
9,595
 
Provision for income taxes
                           
4,186
 
                                 
Net income
                          $
6,829
 


   
Six Months Ended September 30, 2007
 
   
Over-the-Counter
   
Household
   
Personal
       
   
Healthcare
   
Cleaning
   
Care
   
Consolidated
 
                         
Net sales
  $
92,429
    $
60,270
    $
12,182
    $
164,881
 
Other revenues
   
--
     
1,039
     
28
     
1,067
 
                                 
Total revenues
   
92,429
     
61,309
     
12,210
     
165,948
 
Cost of sales
   
35,074
     
37,980
     
7,038
     
80,092
 
                                 
Gross profit
   
57,355
     
23,329
     
5,172
     
85,856
 
Advertising and promotion
   
14,035
     
4,203
     
565
     
18,803
 
                                 
Contribution margin
  $
43,320
    $
19,126
    $
4,607
     
67,053
 
Other operating expenses
                           
23,337
 
                                 
Operating income
                           
43,716
 
Other (income) expense
                           
19,282
 
Provision for income taxes
                           
9,285
 
                                 
Net income
                          $
15,149
 


Prestige Brands Holdings, Inc.
Consolidated Segment Operations
(Unaudited)


   
Three Months Ended September 30, 2006
 
   
Over-the-Counter
Healthcare
   
Household
Cleaning
   
Personal
Care
   
Consolidated
 
                         
Net sales
  $
46,255
    $
30,732
    $
7,046
    $
84,033
 
Other revenues
   
--
     
518
     
--
     
518
 
                                 
Total revenues
   
46,255
     
31,250
     
7,046
     
84,551
 
Cost of sales
   
18,001
     
18,941
     
4,317
     
41,259
 
                                 
Gross profit
   
28,254
     
12,309
     
2,729
     
43,292
 
Advertising and promotion
   
7,058
     
2,020
     
377
     
9,455
 
                                 
Contribution margin
  $
21,196
    $
10,289
    $
2,352
     
33,837
 
Other operating expenses
                           
9,671
 
                                 
Operating income
                           
24,166
 
Other (income) expense
                           
9,743
 
Provision for income taxes
                           
5,639
 
                                 
Net income
                          $
8,784
 


   
Six Months Ended September 30, 2006
 
   
Over-the-Counter
Healthcare
   
Household
Cleaning
   
Personal
Care
   
Consolidated
 
                         
Net sales
  $
85,853
    $
60,470
    $
13,277
    $
159,600
 
Other revenues
   
--
     
874
     
--
     
874
 
                                 
Total revenues
   
85,853
     
61,344
     
13,277
     
160,474
 
Cost of sales
   
32,398
     
37,095
     
8,091
     
77,584
 
                                 
Gross profit
   
53,455
     
24,249
     
5,186
     
82,890
 
Advertising and promotion
   
12,483
     
3,710
     
664
     
16,857
 
                                 
Contribution margin
  $
40,972
    $
20,539
    $
4,522
     
66,033
 
Other operating expenses
                           
18,518
 
                                 
Operating income
                           
47,515
 
Other (income) expense
                           
19,535
 
Provision for income taxes
                           
10,940
 
                                 
Net income
                          $
17,040
 

 

 











Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

AST
6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449
help@astfinancial.com
https://www.astfinancial.com

Subscribe

Stay up to date with investor news, stock information and SEC filings.
Subscribe »